Eretz.bio serves as a center of excellence for validating innovative technologies, drawing on the expertise of Hospital Israelita Albert Einstein with rigorous scientific methodology. The goal is to offer complete and integrated solutions that ensure the effectiveness, safety and feasibility of new technologies in the healthcare sector. Activities include technical and functional validation of technologies, detailed analysis of solutions, support on regulatory issues, definition of go-to-market strategies and usability studies. Based on reliable data and expert feedback, Eretz provides fundamental information for the development and implementation of innovative solutions aligned with the real demands of the market and the needs of patients. Its commitment is centered on scientific excellence and care for the safety and well-being of patients, ensuring that each validated technology has a positive and transformative impact on the healthcare sector.
Eretz.bio provides specialized support to transform innovative ideas into validated, market-ready solutions. With extensive experience working with hundreds of national and international startups, Eretz offers technological validation, guidance on regulatory processes and the generation of robust evidence. All expert feedback is based on data, helping you to strategically structure your go-to-market, demonstrate the benefits of your technology and accelerate the growth of your business.
Einstein, in partnership with Eretz.bio, is offering startups the chance to present their innovative solutions with the potential to be incorporated into one of the world’s most respected healthcare institutions. If your technology or solution can add value to the institution’s operations, improve the patient experience, optimize processes or promote advances in healthcare, get in touch with Eretz.
Corporates can count on the technical and scientific backing of Einstein’s specialists, recognized for their vast experience in the public and private healthcare systems. Eretz offers careful assessment throughout the entire product development and validation journey, ensuring that each stage is conducted rigorously, efficiently and with a focus on commercial success and patient safety.
Conduct the necessary scientific research with Eretz.bio to determine the safety and efficacy of your new technology, following all the...
Get support to carry out in vitro and in vivo laboratory tests to assess efficacy and safety (toxicity, pharmacological safety...
Get access to state-of-the-art infrastructure to carry out exploratory laboratory tests in vitro and in vivo to prove the concept...
Receive analysis to understand the market and consumer needs, including competitors' products and services (such as price, quality, and distribution...
Get access to insights from Einstein's doctors and multidisciplinary professionals, who work in both the private and public healthcare systems,...
You can count on support in designing your regulatory strategy and receive specialized support in the approval process with Anvisa,...
Eretz.bio is the innovation hub of Hospital Israelita Albert Einstein, selected asBrazil's most innovative organization in Prêmio Valor Inovação 2024 . This achievement reflects Eretz.bio commitment to excellence and the transformation of the healthcare sector.
Our team is made up of highly qualified professionals from different areas, with vast experience in health innovation and a history of collaboration with renowned companies in Brazil and abroad
Technologies are evaluated in an institution with international recognition for its scientific excellence and high-standard infrastructure, ensuring reliable and market-applicable results.
Located in Brazil, the world's 8th largest economy, Eretz.bio is a strategic entry point to Latin America. With more than 200 million inhabitants and great ethnic and genetic diversity, Brazil offers an ideal environment for technology validation and expansion opportunities in emerging markets.
